Lead Product(s) : Lidocaine,Prilocaine
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Zydus Lifesciences gets USFDA Nod for Generic Topical Anaesthetic Cream
Details : Lidocaine and Prilocaine cream is indicated as a topical anaesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery.
Product Name : EMLA-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 19, 2024
Lead Product(s) : Lidocaine,Prilocaine
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lidocaine,Prilocaine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Wanbang Biopharmaceuticals
Deal Size : $4.0 million
Deal Type : Licensing Agreement
Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application
Details : Under the License Agreement Regent Pacific is now entitled to receive a payment of approximately HK$6.24 million from Wanbang Pharmaceutical, which is payable within 30 business days. NMPA will now formally review Senstend™ for Clinical Trial Approval.
Product Name : Senstend
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
February 12, 2020
Lead Product(s) : Lidocaine,Prilocaine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Wanbang Biopharmaceuticals
Deal Size : $4.0 million
Deal Type : Licensing Agreement
Reset All
